Hide Board Information

Show Board Information

General Employment Enterprises JOB

Board Mod: Add me as mod

Asst Mods:

Last Post: 05/30/2023 9:35:23 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 1

1. JOB Company Profile

    

2. JOB Time & Sales

    

3. JOB Recent News

    

4. JOB Filings

    

5. JOB Financials

    

6. JOB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	JOB 50% v6,3M c1.62 f17,6M H1.6 power hour pop	znewcar1	08/06/2020 4:45:31 PM
5	JOB 192% v80,5M c1.50 f15,8M J2.49 gap go	znewcar1	07/02/2020 11:23:29 PM
4	JOB 36% v2,5M c.5402 f15,8M H.56	znewcar1	06/09/2020 5:02:32 PM
3	JOB Stock year to date has changed -2.48%	Jake13	03/11/2015 12:17:25 AM
2	JOB 1.18 General Employment Enterprises Stock	chartguy89	03/11/2015 12:15:03 AM
1	JOB 1.11 General Employment Enterprises Stock	chartguy89	03/03/2015 5:04:25 AM

Newer

Recent Articles

• Celebrating Cinema at the 20th China Film Huabiao Awards
• Movado Group Faces SEC Scrutiny, Rosen Law Firm Steps In
• Experience the Thrill of Japan Open Poker Tour 2025
• A.I.S. Resources Completes Successful Private Placement Initiative
• Ready Capital Shareholder Legal Updates: Know Your Rights
• Investors Urged to Act: Lawsuits Filed Against e.l.f. Beauty
• Understanding Your Rights as a Bancorp Investor in Legal Matters
• Important Update for Viatris Investors: Legal Action Insights
• AppLovin Investors Reminded of Important Class Action Deadline
• Investors Have a Deadline to Join NET Power Class Action
• Fluence Energy Class Action Update: Important Deadline Approaches
• AppLovin Corporation Faces Shareholder Class Action Opportunities
• Formosa Pharmaceuticals Partners With Saval For New Eye Treatment
• Antengene Showcases Innovative Therapeutics at AACR Event
• 51Talk Online Education Group Releases Key Annual Report for 2024
• Skye Bioscience Unveils Stock Option Grant for New Employee
• Innovent Celebrates NMPA Approval of Limertinib for Lung Cancer Treatment
• Willow Biosciences Reveals Results from Recent Shareholder Meeting
• Investigation into Bitfarms Ltd: What Investors Should Know
• Investigation into HealthEquity, Inc. Sparks Investor Interest
• Creative Science Expands Horizons with Astaria Global Acquisition
• Investors Encouraged to Join Canopy Growth Class Action Suit
• Rosen Law Firm Initiates Investigation for Bitfarms Investors
• Agnico Eagle's 2025 Shareholder Meeting: Directors Elected
• Orbia's Exciting Offer: Tender for Senior Notes Unveiled
• Concord Medical Submits Annual Report for Fiscal Year 2024
• BankFirst Capital Corporation Posts Strong Q1 Performance
• Espire Dental Unifies Workforce at Engaging Conference Event
• Aliya Health Group Welcomes New Leaders to Enhance Care
• 17 Education & Technology Group Inc. Releases Annual Financial Report
• Kellanova Board Approves New $0.57 Dividend for Shareholders
• Exploring Christian Zionism: New Podcast Series Launches
• Graze Robotics and Invited Launch Pioneering Mowing Initiative
• Medtronic's OmniaSecure Lead Revolutionizes Cardiac Care Innovations
• Celebrate Planning with Plum Paper's Customer Appreciation Sale
• Innovative Grant Initiative to Foster Community Health Equity
• Investigating the HarborOne Bancorp and Eastern Bankshares Deal
• Celularity Faces Delisting Notice From Nasdaq Over Fees
• Paul Mueller Company Q1 Earnings Show Significant Growth
• Trillion Energy Takes Major Steps to Restructure Debt Efficiently
• Credicorp Ltd. Files Annual Report Showcasing Growth Insights
• Wheels Up's Commitment to Strategic Growth Amid NYSE Notice
• Fairfax Financial Holdings to Host Conference Call for Q1 Results
• AGF Investments Reveals New Final Distribution for ETF Holders
• Lug's Commitment to Sensory Accessibility with KultureCity Partnership
• Cadence Bank and Industry Bancshares Join Forces in Merger
• Zepp Health Corporation Announces Filing of 2024 Annual Report
• Innovative Neuro-Oncology Solutions with Dr. Neil A. Martin
• Integral Metals Enhances Marketing Strategy with Extension Plans
• NIP Group Set to Unveil Financial Performance Soon